Literature DB >> 7299243

Endogenous accumulation products and serum protein binding in uremia.

P J McNamara, D Lalka, M Gibaldi.   

Abstract

A number of compounds known to accumulate in the blood of uremic patients were added to serum from healthy normal volunteers. It was observed that both hippuric acid and indican were capable of increasing substantially the serum f of both diazepam and warfarin. Furthermore, a mixture of nine different accumulation products (many of which did not measurably increase f when added alone) caused an even greater increase in the f of diazepam. Serum from uremic patients and from normal volunteers, with and without the addition of the compounds known to accumulate in uremia, wee treated by standard procedures (i.e., prolonged dialysis, charcoal treatment, pH alteration) to remove associated small molecules. The results of such treatments suggest that at least part of the diminished binding of drugs seen in the presence of uremia is due to the accumulation of low-molecular-weight endogenous competitors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299243

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 2.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 3.  Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.

Authors:  T A Golper; W M Bennett
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

4.  Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.

Authors:  Amitava Dasgupta; Bonnette Davis; Loretta Chow
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

5.  Effect of albumin distribution. A simulation analysis of the effect of altered albumin distribution on the apparent volume of distribution and apparent elimination rate constant of drugs.

Authors:  M Shimoda; E Kokue; T Hayama; T B Vree
Journal:  Pharm Weekbl Sci       Date:  1989-06-23

Review 6.  Factors influencing drug protein binding in patients with end stage renal failure.

Authors:  R Vanholder; R De Smet; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

8.  Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.

Authors:  C Aguirre; J M Rodríguez-Sasiain; R Calvo
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Production of antiserum for sensitive enzyme-linked immunosorbent assay of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid by chemiluminescence.

Authors:  T Tanaka; H Ikebuchi; J Sawada; Y Tanaka
Journal:  Lipids       Date:  1998-07       Impact factor: 1.880

Review 10.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.